Matches in Nanopublications for { ?s ?p "[In this paper we demonstrate that bezafibrate, a PPAR pan agonist used for the treatment of patients with hyperlipidaemia reduces VLCFA levels in X-ALD fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP642477.RAfldOAX9IuuP2aL54i1gHrBXM2lhj45hxgX7AAIbkjXM130_assertion description "[In this paper we demonstrate that bezafibrate, a PPAR pan agonist used for the treatment of patients with hyperlipidaemia reduces VLCFA levels in X-ALD fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642477.RAfldOAX9IuuP2aL54i1gHrBXM2lhj45hxgX7AAIbkjXM130_provenance.
- NP437758.RATKj6edtm8AQYnBrPb52eekZxDM1P8aLNe9dzdFhjDTE130_assertion description "[In this paper we demonstrate that bezafibrate, a PPAR pan agonist used for the treatment of patients with hyperlipidaemia reduces VLCFA levels in X-ALD fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437758.RATKj6edtm8AQYnBrPb52eekZxDM1P8aLNe9dzdFhjDTE130_provenance.
- NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_assertion description "[In this paper we demonstrate that bezafibrate, a PPAR pan agonist used for the treatment of patients with hyperlipidaemia reduces VLCFA levels in X-ALD fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_provenance.
- NP970251.RA9S1qBCCb2kx5B6VKPULRmu-fs7yEFs8iEL-0NN8hs7E130_assertion description "[In this paper we demonstrate that bezafibrate, a PPAR pan agonist used for the treatment of patients with hyperlipidaemia reduces VLCFA levels in X-ALD fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP970251.RA9S1qBCCb2kx5B6VKPULRmu-fs7yEFs8iEL-0NN8hs7E130_provenance.
- NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_assertion description "[In this paper we demonstrate that bezafibrate, a PPAR pan agonist used for the treatment of patients with hyperlipidaemia reduces VLCFA levels in X-ALD fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_provenance.
- NP636518.RAONwyqVHUwqO6vPyJlJfMLj4vjyd1tcH2Yu7g5BVn3Fc130_assertion description "[In this paper we demonstrate that bezafibrate, a PPAR pan agonist used for the treatment of patients with hyperlipidaemia reduces VLCFA levels in X-ALD fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636518.RAONwyqVHUwqO6vPyJlJfMLj4vjyd1tcH2Yu7g5BVn3Fc130_provenance.
- assertion description "[In this paper we demonstrate that bezafibrate, a PPAR pan agonist used for the treatment of patients with hyperlipidaemia reduces VLCFA levels in X-ALD fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In this paper we demonstrate that bezafibrate, a PPAR pan agonist used for the treatment of patients with hyperlipidaemia reduces VLCFA levels in X-ALD fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.